-
1دورية أكاديمية
المؤلفون: Magrath JW; Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana., Sampath SS; Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana., Flinchum DA; Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana., Hartono AB; Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana., Goldberg IN; Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana., Boehling JR; Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana., Savkovic SD; Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana., Lee SB; Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana.
المصدر: Cancer research [Cancer Res] 2024 May 02; Vol. 84 (9), pp. 1426-1442.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Cyclin-Dependent Kinase 4*/antagonists & inhibitors , Cyclin-Dependent Kinase 4*/genetics , Cyclin-Dependent Kinase 6*/antagonists & inhibitors , Cyclin-Dependent Kinase 6*/genetics , Desmoplastic Small Round Cell Tumor*/genetics , Desmoplastic Small Round Cell Tumor*/drug therapy , Desmoplastic Small Round Cell Tumor*/pathology , Desmoplastic Small Round Cell Tumor*/metabolism , Oncogene Proteins, Fusion*/genetics , Oncogene Proteins, Fusion*/metabolism , Piperazines*/pharmacology , Piperazines*/therapeutic use , Pyridines*/pharmacology , Pyridines*/therapeutic use , RNA-Binding Protein EWS*/genetics , RNA-Binding Protein EWS*/metabolism , Xenograft Model Antitumor Assays*, Animals ; Humans ; Mice ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic/drug effects ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; WT1 Proteins/genetics ; WT1 Proteins/metabolism ; Mice, Inbred NOD